Key points are not available for this paper at this time.
Radiopharmaceutical therapy (RPT) is established as an innovative, effective, and well-tolerated treatment platform approved for well-differentiated neuroendocrine tumors and advanced prostate cancer (PC) and is being investigated in many other cancers such as breast, lung, and thyroid (11–[3
Poschenrieder et al. (Thu,) studied this question.